Crunchbase News

DECEMBER 5, 2024

While some things tend to slow as the year winds down, artificial intelligence fundraising apparently isn’t one of them. xAI , $5B, artificial intelligence: Generative AI startup xAI raised $5 billion in a round valuing it at $50 billion, The Wall Street Journal reported. and AI product development.

Artificial Inteligence 124

Artificial Inteligence Artificial Intelligence Generative AI Biotech 124

Crunchbase News

NOVEMBER 12, 2024

Writer’s platform is designed to help businesses use large language models to improve workflows and offers AI solutions that can execute complex enterprise operations across systems and teams. Existing investors Accenture , Balderton Capital , Insight Partners and Vanguard also participated.

Artificial Inteligence 121

Artificial Inteligence Artificial Intelligence Retail Generative AI 121

Crunchbase News

NOVEMBER 1, 2024

OpenAI , $6.6B, artificial intelligence: OpenAI announced its long-awaited raise of $6.6 tied) Poolside , $500M, artificial intelligence: Poolside closed a $500 million Series B led by Bain Capital Ventures. The startup builds artificial intelligence software for programmers. billion, per Crunchbase.

Biotech 120

Biotech Energy Artificial Intelligence Artificial Inteligence 120

N2Growth Blog

OCTOBER 23, 2023

Understanding the Unique Challenges in Recruiting for Biotech and Life Sciences The recruitment process in the biotech and life sciences industry comes with its own set of unique challenges. One of the primary obstacles is the need for more highly skilled and qualified talent.

Biotech 178

Biotech Strategy Artificial Inteligence Recruiting 178

CIO

MARCH 4, 2025

Artificial intelligence: Driving ROI across the board AI is the poster child of deep tech making a direct impact on business performance. Biotechnology and synthetic biology: The swift development of mRNA vaccines in 2020 illustrated biotechs unprecedented speed in delivering transformative products.

Technology 177

Technology Biotech Artificial Intelligence Artificial Inteligence 177

Crunchbase News

DECEMBER 9, 2024

Biotech offerings, while more plentiful, are also running well below prior highs. Below, we pick out winners and losers for venture-backed tech and biotech companies, focusing on large- and medium-sized IPOs. Top biotech performers Biotech companies that debuted on public markets this year also saw plenty of ups and downs.

Biotech 120

Biotech Film Performance Marketing 120

TechCrunch

FEBRUARY 11, 2021

Just three years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million. ” Mission Bio raises $70 million to help scale its tech for improving the development of targeted cancer therapies.

Artificial Inteligence 305

Artificial Inteligence Machine Learning Biotech Chemicals 305

Crunchbase News

NOVEMBER 22, 2024

To a great degree, the largest rounds of the year went to a handful of AI companies working on large language models and underlying technologies to scale them. While the Boston startup scene is famous for biotech and deeptech talent, the city has lagged other hubs in creation of ultra-high-valuation AI unicorns.

Technical Review 131

Technical Review Artificial Inteligence Biotech Energy 131

Crunchbase News

FEBRUARY 4, 2025

Venture money wasnt concentrated in just one sector, as VCs invested in everything from artificial intelligence to biotech to energy. tied) Anthropic , $1B, artificial intelligence: Anthropic, a ChatGPT rival with its AI assistant Claude, is reportedly taking in a fresh $1 billion investment from previous investor Google.

Biotech 121

Biotech Artificial Intelligence Artificial Inteligence Technical Review 121

TechCrunch

DECEMBER 16, 2022

6 investors discuss why AI is more than just a buzzword in biotech. In her latest investor survey, Anna Heim spoke to six biotech investors about where AI creates value, short-term market shifts, and how they’d like to be approached by founders: Robert Mittendorff, M.D, general partner and head of healthcare, B Capital.

Case Study 215

Case Study Biotech Survey Study 215

TechCrunch

SEPTEMBER 13, 2022

French biotech company WhiteLab Genomics has raised $10 million in funding for an AI platform designed to aid the discovery and development of genomic therapies. However, such therapies are typically costly to develop with no guarantee that they’ll work.

Biotech 258

Biotech Development Pharmaceuticals Artificial Inteligence 258

Crunchbase News

MARCH 28, 2025

Fleetio , $450M, fleet management: Fleet optimization software platform developer Fleetio locked up a $450 million round to finance the acquisition of maintenance authorization platform Auto Integrate. Island , $250M, cybersecurity: Dallas-based enterprise browser developer Island raised a $250 million Series E at a $4.8

Biotech 98

Biotech Artificial Intelligence Artificial Inteligence Transportation 98

TechCrunch

NOVEMBER 22, 2022

Artificial intelligence has become ubiquitous in clinical diagnosis. “We see ourselves building the foundational layer of artificial intelligence in healthcare. Healthtech startup RedBrick AI has raised $4.6 But researchers need much of their initial time preparing data for training AI systems.

Artificial Inteligence 234

Artificial Inteligence Artificial Intelligence Biotech 3D 234

TechCrunch

DECEMBER 2, 2020

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. Machine learning has, of course, accelerated work in many fields, biochemistry among them, but he felt that the potential of the technology had not been tapped.

Biotech 265

Biotech 3D Artificial Inteligence Machine Learning 265

TechCrunch

OCTOBER 3, 2022

The software company was developed at Colossal Biosciences — known for its goal to bring extinct critters like the wooly mammoth back to life — and is now striking out on its own. As companies aim to cut costs and reel in spending amid uncertain macroeconomic conditions, Form Bio thinks it is actually the perfect time to launch its platform.

Biotech 240

Biotech Software Artificial Inteligence Machine Learning 240

Crunchbase News

NOVEMBER 22, 2024

Just as the holiday season begins, a sleighful of companies unveiled large funding rounds. xAI , $5B, artificial intelligence: Generative AI startup xAI raised $5 billion in a funding round valuing it at $50 billion, The Wall Street Journal reported. The $6 billion round valued the company at $24 billion post money.

Artificial Intelligence 118

Artificial Intelligence Artificial Inteligence Biotech Generative AI 118

TechCrunch

JUNE 6, 2022

Insilico Medicine, a Hong Kong-based company that has been using artificial intelligence to discover new drugs since 2014, has completed a fresh round of funding. This presents an opportunity for Insilico Medicine to emerge as a winner during the biotech spring.” It has nominated eight preclinical candidates since 2021.

Biotech 211

Biotech Artificial Intelligence Artificial Inteligence Pharmaceuticals 211

Crunchbase News

JUNE 21, 2024

Biotech/healthcare and cybersecurity dominated the run of big rounds this week, with a few AI startups also seeing good-sized checks. Marea Therapeutics , $190M, biotech: This big biotech round is actually the combination of two rounds. The top five raises this week came from sectors that have seen good heat recently.

Biotech 112

Biotech Artificial Intelligence Artificial Inteligence Healthcare 112

Crunchbase News

JANUARY 9, 2025

billion to develop data centers in Spain. In 2023, it partnered with Digital Realty to develop $7 billion in data centers targeting providers of online content, cloud services and artificial intelligence. Last year it was reported the worlds largest asset manager plans to invest $8.2

Storage 120

Storage Data Center Artificial Intelligence Artificial Inteligence 120

TechCrunch

MAY 26, 2021

So a new crop of biotech companies have worked to integrate these aspects. “Next year, we anticipate having our first drug candidate enter the late preclinical phase of development and regulatory work for an IND (investigational new drug) filing with the FDA, and starting the clinical trials in 2023.”

Engineering 248

Engineering Biotech Chemicals Artificial Inteligence 248

TechCrunch

MAY 20, 2022

With cloud-based servers and sophisticated, yet inexpensive, sensors both on the body and off, patients can be monitored at home more effectively than in a hospital, especially when the sensor data is analyzed with artificial intelligence (AI) and machine-learning technology. Opportunities for digital biomarkers.

Artificial Inteligence 231

Artificial Inteligence Artificial Intelligence Healthcare Technical Review 231

Crunchbase News

DECEMBER 15, 2023

The week was especially good for biotech, which led the way with two big raises. Tome Biosciences , $213M, biotech: A big biotech raise hit high on the list this week. The company plans to use the tech to develop gene therapies for monogenic liver diseases and cell therapies for autoimmune diseases.

Biotech 118

Biotech Artificial Intelligence Artificial Inteligence Hotels 118

Crunchbase News

MARCH 8, 2024

However, this week it was clearly biotech leading the way, with three startups from the sector nabbing spots in the top five. Alumis , $259M, biotech: This week saw the biggest biotech raise of the year thus far. The startup is developing oral therapies for patients with immune-mediated diseases.

Biotech 116

Biotech Pharmaceuticals Systems Review Artificial Intelligence 116

TechCrunch

JANUARY 25, 2022

Meanwhile, the company is developing machine learning algorithms with the ability to pick out subpar cells. . In the long term, Cellino is aiming toward developing a iPSC-derived retinal pigment epithelium product. In an increasingly hot biotech market, protecting IP is key.

Artificial Inteligence 246

Artificial Inteligence Machine Learning Biotech Study 246

Crunchbase News

MAY 24, 2024

Nevertheless, the week saw a $1 billion round go to yet another AI startup, and biotech and blockchain also saw some big deals. Scale AI , $1B, artificial intelligence: This week was like many — one topped with a big AI round. The startup will use the new cash to grow its user base and add developer tools.

Artificial Inteligence 118

Artificial Inteligence Biotech Artificial Intelligence Healthcare 118

Crunchbase News

JUNE 4, 2024

xAI , $6B, artificial intelligence: Elon Musk ’s generative AI startup, xAI , officially announced its long-awaited fundraise — making it the second-most-valuable generative AI company in the world behind only competitor OpenAI. It introduced its latest AI model, called Grok-1.5, earlier this year.

Artificial Inteligence 122

Artificial Inteligence Biotech Artificial Intelligence Generative AI 122

TechCrunch

AUGUST 15, 2022

In addition to biotech, Russek felt there also needed to be software and automation components. Finally, artificial intelligence-powered automation and engineering components are designed to remote-monitor the water quality, regulate temperature and oxygenation and feed the shrimp. So they created Atarraya, a U.S.-based

Technology 238

Technology Biotech Artificial Intelligence Artificial Inteligence 238

Crunchbase News

JUNE 28, 2024

Formation Bio , $372M, biotech: Every week there is a big biotech raise and this week’s is really big. More and more biotech startups are using AI to help with their drug processes and investors are clearly taking note. The San Francisco-based company has developed a telenutrition and food benefits management platform.

Artificial Inteligence 113

Artificial Inteligence Biotech Generative AI Healthcare 113

Crunchbase News

AUGUST 9, 2024

Aside from that, the week saw some big rounds from cybersecurity, travel and of course, biotech. The company will use some of the new proceeds for the development of Arsenal-1 — a more than 5 million-square-foot production space designed to produce tens of thousands of autonomous military systems annually. billion.

Biotech 118

Biotech Artificial Inteligence Industry Artificial Intelligence 118

TechCrunch

APRIL 12, 2022

“Searching for the right solution led the team deep into machine learning techniques, which came with requirements to use large amounts of data and deliver robust models to production consistently … The techniques used were platformized, and the solution was used widely at Lyft.” ” Taking Flyte.

Artificial Inteligence 202

Artificial Inteligence Machine Learning Open Source Biotech 202

Crunchbase News

APRIL 2, 2024

Wonder ’s big $700 million raise may have captured most people’s attention last month, but the story when it came for large deals was really biotech. That makes it quite the month for startups looking to develop drugs and therapies for all that ails us. That sector saw seven of the rounds on this list. billion, per Crunchbase.

Biotech 114

Biotech Generative AI Automotive Industry 114

TechCrunch

JANUARY 25, 2022

The Tunisian startup, headquartered in London with offices in Paris, Tunis, Lagos, Dubai and Cape Town, uses advanced machine learning techniques to bring AI to applications within an enterprise environment. The lab’s mandate was to deploy the latest advances in AI and ML to develop novel immunotherapies.

Enterprise 246

Enterprise Artificial Inteligence Machine Learning Transportation 246

Crunchbase News

JULY 19, 2024

Eight startups raised $100 million or more this week as a biotech and financial services company led the way. The startup is focused on developing therapeutics for the treatment of cardiovascular diseases. Scorpion Therapeutics , $150M, biotech: Yet another big biotech round. Notice anything missing?

Pharmaceuticals 116

Pharmaceuticals Biotech Artificial Inteligence Automotive 116

Crunchbase News

OCTOBER 1, 2024

However, it wasn’t just AI that got funding in September, as biotech makes up about half the list. Safe Superintelligence , $1B, artificial intelligence: AI research lab Safe Superintelligence raised $1 billion from a litany of big-name investors including Andreessen Horowitz and Sequoia Capital.

Biotech 116

Biotech Artificial Intelligence Artificial Inteligence Travel 116

TechCrunch

JANUARY 31, 2022

It’s also a key pillar of Gandeeva, a new biotech company that emerged from stealth on Monday with a $40 million Series A round. The company plans to combine this high-resolution imagery with a suite of machine learning tools to speed up the process of drug discovery. “It Image Credits: Gandeeva Therapeutics.

Artificial Inteligence 231

Artificial Inteligence Machine Learning Biotech Government 231

TechCrunch

APRIL 19, 2022

. “We use data combined from a large number of previously-run clinical trials. Our product is not an AI model — it’s a clinical trial,” CEO Charles Fisher told TechCrunch via email. “[Our] intention wasn’t to speed clinical trials — it was pure research into machine learning.

Development 170

Development Pharmaceuticals Artificial Inteligence Machine Learning 170

Crunchbase News

FEBRUARY 28, 2025

After a couple of blistering weeks, large funding rounds slowed down to a crawl, with only two rounds hitting nine figures. Not surprisingly, those two rounds came from the cybersecurity and biotech industries. Eikon Therapeutics , $351M, biotech: Eikon Therapeutics raised one of the biggest biotech rounds thus far in this young year.

Biotech 73

Biotech Artificial Intelligence Artificial Inteligence Healthcare 73